Company: INV
Filing Date: 2025-04-15
Form Type: S-1
Source: 0001628280-25-017890
Chunk: 34

Company: Innventure, Inc.
Filing Date: 2025-04-15
Form: S-1
Chunk 34
---
 may be subject to increased regulatory scrutiny due to their use of working fluid

refrigerants that contain fluorine.

The market and/or regulatory agencies inside and outside the United States may elect to curtail the use of

polyfluoroalkyl substances, including hydrofluoroolefins and hydrochlorofluoroolefins, due to their persistence in

the environment, their global warming potential, or their ozone depletion potential. While Accelsius believes it

follows industry best practices in respect of its use of these commonly available refrigerants as working fluids in

Accelsius’ cooling products, unforeseen regulatory changes that limit availability or manufacturing capacity or

increase material prices would adversely affect Accelsius business.

17

The market, including customers and potential investors, may be skeptical of the viability and benefits of

Accelsius’ and Refinity’s products and processes because they are based on relatively novel and complex

technology.

The market, including customers and potential investors, may be skeptical of the viability and benefits of

Accelsius’ and Refinity’s products and processes because they are based on relatively novel and complex

technology. There can be no assurance that Accelsius’ and Refinity’s products and processes will be understood,

approved, or accepted by customers and potential investors or that Accelsius or Refinity will be able to sell its

products profitably at competitive prices and with features sufficient to establish demand or to design and build a

plastic waste to drop-in chemicals plant on budget or profitably operate such a plant, respectively. If Accelsius and

Refinity are unable to convince these potential customers of the utility and value of their products and processes or

that their solutions are superior to those they currently use, they will not be successful in entering those markets and

their business and results of operations will be adversely affected. If potential investors are skeptical of the success

of Accelsius’ and Refinity’s products and processes, their ability to raise capital and the value of Innventure stock

may be adversely affected.

The failure of AFX’s suppliers to continue to deliver necessary raw materials or other components of its products

in a timely manner and to specification could prevent it from delivering products within required time frames and

could cause production delays, cancellations, penalty payments and damage to its brand and reputation.

AFX is early in the development of its commercial production capacity and has not yet fully diversified

suppliers for critical raw materials, specifically its film.

Thus far, AFX has qualified one incumbent raw material film supplier—a large, foreign